Francesco Spedicato

Dr. Francesco Spedicato

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2023 in Genes
Verified
Journal Article
Open access
PDF file
LGLaura Giannotti
Laura Giannotti
BSBenedetta Di Chiara Stanca
Benedetta Di Chiara Stanca
FSFrancesco Spedicato
Francesco Spedicato
Paola NittiPaola Nitti
Paola Nitti
Fabrizio DamianoFabrizio Damiano
Fabrizio Damiano
ESEleonora Stanca
Eleonora Stanca
The goal of regenerative medicine is to achieve tissue regeneration. In the past, commonly used techniques included autologous or allogeneic transplantation and stem cell therapy, which have limitations, such as a lack of donor sites in the case of autologous transplantation and the invasiveness of stem cell harvesting. In recent years, research has, therefore, focused on new and less invasive strategies to achieve tissue regeneration. A step forward in this direction has been made with the development of autologous platelet concentrates (APCs), which are derived from the patient’s own blood. They can be classified into three generations: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factors (CGFs). These APCs have different structural characteristics, depending on the distinctive preparation method, and contain platelets, leukocytes, and multiple growth factors, including those most involved in regenerative processes. The purpose of this review is to clarify the most used techniques in the field of regenerative medicine in recent years, comparing the different types of APCs and analyzing the preparation protocols, the composition of the growth factors, the level of characterization achieved, and their clinical applications to date.

2 December 2022 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
LSLuisa Siculella
Luisa Siculella
LGLaura Giannotti
Laura Giannotti
BSBenedetta Di Chiara Stanca
Benedetta Di Chiara Stanca
FSFrancesco Spedicato
Francesco Spedicato
MCMatteo Calcagnile
Matteo Calcagnile
Fabrizio DamianoFabrizio Damiano
Fabrizio Damiano

26 December 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
LGLaura Giannotti
Laura Giannotti
BSBenedetta Di Chiara Stanca
Benedetta Di Chiara Stanca
FSFrancesco Spedicato
Francesco Spedicato
Daniele VergaraDaniele Vergara
Daniele Vergara
ESEleonora Stanca
Eleonora Stanca
LSLuisa Siculella
Luisa Siculella
Cannabinoids include both endogenous endocannabinoids and exogenous phytocannabinoids, such as cannabidiol (CBD), and have potential as therapeutic agents in cancer treatment due to their selective anticancer activities. CBD exhibits both antioxidant and pro-oxidant effects depending on its concentration and cell types. These properties allow CBD to influence oxidative stress responses and potentially enhance the efficacy of antitumor therapies. In this study, we treated U87MG glioma cells with low dose (1 μM) CBD and evaluated its molecular effects. Our findings indicate that CBD reduced cell viability by 20% (p < 0.05) through the alteration of mitochondrial membrane potential. The alteration of redox status by CBD caused an attempt to rescue mitochondrial functionality through nuclear localization of the GABP transcription factor involved in mitochondria biogenesis. Moreover, CBD treatment caused an increase in autophagic flux, as supported by the increase in Beclin-1 and the ratio of LC3-II/LC3-I. Due to mitochondria functionality alteration, pro-apoptotic proteins were induced without activating apoptotic effectors Caspase-3 or Caspase-7. The study of the transcription factor NRF2 and the ubiquitin-binding protein p62 expression revealed an increase in their levels in CBD-treated cells. In conclusion, low-dose CBD makes U87MG cells more vulnerable to cytotoxic effects, reducing cell viability and mitochondrial dynamics while increasing autophagic flux and redox systems. This explains the mechanisms by which glioma cells respond to CBD treatment. These findings highlight the therapeutic potential of CBD, suggesting that modulating NRF2 and autophagy pathways could represent a promising strategy for glioblastoma treatment.

30 March 2023 in Biology
Verified
Journal Article
Open access
PDF file
LGLaura Giannotti
Laura Giannotti
BSBenedetta Di Chiara Stanca
Benedetta Di Chiara Stanca
Paola NittiPaola Nitti
Paola Nitti
FSFrancesco Spedicato
Francesco Spedicato
Fabrizio DamianoFabrizio Damiano
Fabrizio Damiano
ESEleonora Stanca
Eleonora Stanca
The application of scaffolding materials together with stem cell technologies plays a key role in tissue regeneration. Therefore, in this study, CGF (concentrated growth factor), which represents an autologous and biocompatible blood-derived product rich in growth factors and multipotent stem cells, was used together with a hydroxyapatite and silicon (HA-Si) scaffold, which represents a very interesting material in the field of bone reconstructive surgery. The aim of this work was to evaluate the potential osteogenic differentiation of CGF primary cells induced by HA-Si scaffolds. The cellular viability of CGF primary cells cultured on HA-Si scaffolds and their structural characterization were performed by MTT assay and SEM analysis, respectively. Moreover, the matrix mineralization of CGF primary cells on the HA-Si scaffold was evaluated through Alizarin red staining. The expression of osteogenic differentiation markers was investigated through mRNA quantification by real-time PCR. We found that the HA-Si scaffold was not cytotoxic for CGF primary cells, allowing their growth and proliferation. Furthermore, the HA-Si scaffold was able to induce increased levels of osteogenic markers, decreased levels of stemness markers in these cells, and the formation of a mineralized matrix. In conclusion, our results suggest that HA-Si scaffolds can be used as a biomaterial support for CGF application in the field of tissue regeneration.

Verified
Journal Article
Open access
PDF file
LGLaura Giannotti
Laura Giannotti
BSBenedetta Di Chiara Stanca
Benedetta Di Chiara Stanca
FSFrancesco Spedicato
Francesco Spedicato
ESEleonora Stanca
Eleonora Stanca
Fabrizio DamianoFabrizio Damiano
Fabrizio Damiano
LSLuisa Siculella
Luisa Siculella
N-methylpyridinium (NMP) is produced through the pyrolysis of trigonelline during the coffee bean roasting process. Preliminary studies suggest that NMP may have health benefits, thanks to its antioxidant properties. Based on this background, the aim of this study was to evaluate whether NMP could have a protective effect against LPS-induced neuroinflammation in human glioblastoma cells (U87MG). With this aim, U87MG cells were pre-treated with NMP (0.5 μM) for 1 h and then exposed to LPS (1 μg/mL) for 24 h. Our findings show that NMP attenuates LPS-induced neuroinflammation by reducing the expression of pro-inflammatory cytokines, such as IL-1β, TNF-α and IL-6, through the inhibition of the NF-κB signaling pathway, which is critical in regulating inflammatory responses. NMP is able to suppress the activation of the NF-κB signaling pathway, suggesting its potential in preventing neuroinflammatory conditions. These outcomes support the notion that regular consumption of NMP, possibly through coffee consumption, may offer protection against neuroinflammatory states implicated in neurological disorders.

Verified
Journal Article
Open access
PDF file
LGLaura Giannotti
Laura Giannotti
NCNadia Calabriso
Nadia Calabriso
FSFrancesco Spedicato
Francesco Spedicato
APAndrea Palermo
Andrea Palermo
BSBenedetta Di Chiara Stanca
Benedetta Di Chiara Stanca
ESEleonora Stanca
Eleonora Stanca
Concentrated growth factor (CGF) is an autologous blood-derived product widely used in regenerative medicine due to its high concentration of growth factors and platelets. In this study, the ability of primary stem cells isolated from human CGF to differentiate into adipocytes, endothelial cells, and neuronal-like cells was evaluated in vitro. CGF primary cells (CPCs) were obtained from CGF fragments and characterized after one month in culture. These cells were positive for the surface markers CD105, CD45, CD31, and CD14, and also expressed mRNA levels of the stemness markers Nanog and Oct3/4 comparable to human bone marrow mesenchymal stem cells (BMSCs). Results showed that, following appropriate differentiation protocols, CPCs, similarly to BMSCs, were able to differentiate into adipogenic, endothelial, and neuronal lineages, acquiring specific phenotypic and molecular markers. Adipogenic induction resulted in lipid accumulation and the upregulation of key genes, including PLIN2, FABP4, CD36, and FASN. Under pro-endothelial conditions, the cells exhibited increased expression of endothelial markers, eNOS, VEGFR-2, and CD31. Neuronal induction promoted the expression of β-tubulin III, Nestin, and Neurofilament. Overall, this work highlights the remarkable plasticity of CPCs and supports their potential application in multilineage regenerative therapies.